Hemogenyx Pharmaceuticals PLC Director/PDMR Shareholding (1101T)

TIDMHEMO

RNS Number : 1101T

Hemogenyx Pharmaceuticals PLC

10 October 2017

Hemogenyx Pharmaceuticals Plc

("Hemogenyx" or the "Company")

Director / PDMR Shareholding

Hemogenyx Pharmaceuticals Plc (LSE: HEMO), the biotechnology company developing novel therapies to transform bone marrow and blood stem cell transplantation, announces that it has been advised that on 6 October 2017 Adrian Beeston, Non-Executive Director, purchased 317,683 ordinary shares of GBP0.01 each in the Company ("Ordinary Shares") at a price of 3.1p per share. Following this transaction Mr Beeston now has an interest in 5,731,969 Ordinary Shares, representing approximately 1.61 per cent. of the Company's issued share capital.

In addition, the Company has been advised that Peter Redmond, Non-Executive Director, purchased 155,000 Ordinary Shares at a price of 3.135p per share on 6 October 2017. Following this transaction Mr Redmond now has an interest in 5,040,714 Ordinary Shares, representing approximately 1.41 per cent. of the Company's issued share capital, which includes shares held in the name of Catalyst Corporate Consultants Limited of which Peter Redmond is a director and sole shareholder.

The Notification of Dealing Forms provided in accordance with the requirements of MAR in relation to the transactions listed above are set out below:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1     Details of the person discharging managerial 
        responsibilities / person closely associated 
----  ----------------------------------------------------------------- 
 a)    Name                            Adrian Beeston 
----  ------------------------------  --------------------------------- 
 2     Reason for the notification 
----  ----------------------------------------------------------------- 
 a)    Position/status                 Non-executive Director 
----  ------------------------------  --------------------------------- 
 b)    Initial notification            Initial notification 
        /Amendment 
----  ------------------------------  --------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  ----------------------------------------------------------------- 
 a)    Name                            Hemogenyx Pharmaceuticals 
                                        Plc 
----  ------------------------------  --------------------------------- 
 b)    LEI                             n/a 
----  ------------------------------  --------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  ----------------------------------------------------------------- 
 a)    Description of                  Ordinary shares of GBP0.01 
        the financial                   each 
        instrument, type 
        of instrument 
---- 
 
       Identification                  ISIN GB00BYX3WZ24 
        code 
 
 b)    Nature of the                   Purchase of Ordinary Shares 
        transaction 
----  ------------------------------  --------------------------------- 
 c)    Price(s) and volume(s) 
----                                   --------------  -------------- 
                                        Price(s)        Volume(s) 
----                                   --------------  -------------- 
                                        3.1p            10,000 
                                       --------------  -------------- 
 
 d)    Aggregated information 
---- 
 
  - Aggregated volume              N/A - single transaction 
 
  - Price 
 
 e)    Date of the transaction         6 October 2017 
----  ------------------------------  --------------------------------- 
 f)    Place of the transaction        London Stock Exchange 
----  ------------------------------  --------------------------------- 
 
 
 1     Details of the person discharging managerial 
        responsibilities / person closely associated 
----  ----------------------------------------------------------------- 
 a)    Name                            Peter Redmond 
----  ------------------------------  --------------------------------- 
 2     Reason for the notification 
----  ----------------------------------------------------------------- 
 a)    Position/status                 Non-executive Director 
----  ------------------------------  --------------------------------- 
 b)    Initial notification            Initial notification 
        /Amendment 
----  ------------------------------  --------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  ----------------------------------------------------------------- 
 a)    Name                            Hemogenyx Pharmaceuticals 
                                        Plc 
----  ------------------------------  --------------------------------- 
 b)    LEI                             n/a 
----  ------------------------------  --------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  ----------------------------------------------------------------- 
 a)    Description of                  Ordinary shares of GBP0.01 
        the financial                   each 
        instrument, type 
        of instrument 
---- 
 
       Identification                  ISIN GB00BYX3WZ24 
        code 
 
 b)    Nature of the                   Purchase of Ordinary Shares 
        transaction 
----  ------------------------------  --------------------------------- 
 c)    Price(s) and volume(s) 
----                                   --------------  -------------- 
                                        Price(s)        Volume(s) 
----                                   --------------  -------------- 
                                        3.135p          155,000 
                                       --------------  -------------- 
 
 d)    Aggregated information 
---- 
 
  - Aggregated volume              N/A - single transaction 
 
  - Price 
 
 e)    Date of the transaction         6 October 2017 
----  ------------------------------  --------------------------------- 
 f)    Place of the transaction        London Stock Exchange 
----  ------------------------------  --------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBSBDGSUGBGRC

(END) Dow Jones Newswires

October 10, 2017 02:00 ET (06:00 GMT)